Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes

For the past several decades, the prevalence of obesity and type 2 diabetes (T2D) has continued to rise on a global level. The risk contributing to this pandemic implicates both genetic and environmental factors, which are functionally integrated by epigenetic mechanisms. While these conditions are...

Full description

Bibliographic Details
Main Authors: Federica Zatterale, Gregory Alexander Raciti, Immacolata Prevenzano, Alessia Leone, Michele Campitelli, Veronica De Rosa, Francesco Beguinot, Luca Parrillo
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/12/7/982
_version_ 1797433792581861376
author Federica Zatterale
Gregory Alexander Raciti
Immacolata Prevenzano
Alessia Leone
Michele Campitelli
Veronica De Rosa
Francesco Beguinot
Luca Parrillo
author_facet Federica Zatterale
Gregory Alexander Raciti
Immacolata Prevenzano
Alessia Leone
Michele Campitelli
Veronica De Rosa
Francesco Beguinot
Luca Parrillo
author_sort Federica Zatterale
collection DOAJ
description For the past several decades, the prevalence of obesity and type 2 diabetes (T2D) has continued to rise on a global level. The risk contributing to this pandemic implicates both genetic and environmental factors, which are functionally integrated by epigenetic mechanisms. While these conditions are accompanied by major abnormalities in fuel metabolism, evidence indicates that altered immune cell functions also play an important role in shaping of obesity and T2D phenotypes. Interestingly, these events have been shown to be determined by epigenetic mechanisms. Consistently, recent epigenome-wide association studies have demonstrated that immune cells from obese and T2D individuals feature specific epigenetic profiles when compared to those from healthy subjects. In this work, we have reviewed recent literature reporting epigenetic changes affecting the immune cell phenotype and function in obesity and T2D. We will further discuss therapeutic strategies targeting epigenetic marks for treating obesity and T2D-associated inflammation.
first_indexed 2024-03-09T10:22:27Z
format Article
id doaj.art-9edcf110c91d47cc98ebc910c78e8b3b
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-09T10:22:27Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-9edcf110c91d47cc98ebc910c78e8b3b2023-12-01T21:56:40ZengMDPI AGBiomolecules2218-273X2022-07-0112798210.3390/biom12070982Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 DiabetesFederica Zatterale0Gregory Alexander Raciti1Immacolata Prevenzano2Alessia Leone3Michele Campitelli4Veronica De Rosa5Francesco Beguinot6Luca Parrillo7Department of Translational Medical Science, Federico II University of Naples, 80131 Naples, ItalyDepartment of Translational Medical Science, Federico II University of Naples, 80131 Naples, ItalyDepartment of Translational Medical Science, Federico II University of Naples, 80131 Naples, ItalyDepartment of Translational Medical Science, Federico II University of Naples, 80131 Naples, ItalyDepartment of Translational Medical Science, Federico II University of Naples, 80131 Naples, ItalyURT Genomic of Diabetes, Institute of Experimental Endocrinology and Oncology, National Research Council, 80131 Naples, ItalyDepartment of Translational Medical Science, Federico II University of Naples, 80131 Naples, ItalyDepartment of Translational Medical Science, Federico II University of Naples, 80131 Naples, ItalyFor the past several decades, the prevalence of obesity and type 2 diabetes (T2D) has continued to rise on a global level. The risk contributing to this pandemic implicates both genetic and environmental factors, which are functionally integrated by epigenetic mechanisms. While these conditions are accompanied by major abnormalities in fuel metabolism, evidence indicates that altered immune cell functions also play an important role in shaping of obesity and T2D phenotypes. Interestingly, these events have been shown to be determined by epigenetic mechanisms. Consistently, recent epigenome-wide association studies have demonstrated that immune cells from obese and T2D individuals feature specific epigenetic profiles when compared to those from healthy subjects. In this work, we have reviewed recent literature reporting epigenetic changes affecting the immune cell phenotype and function in obesity and T2D. We will further discuss therapeutic strategies targeting epigenetic marks for treating obesity and T2D-associated inflammation.https://www.mdpi.com/2218-273X/12/7/982epigeneticsimmune systemobesity and type 2 diabetesinflammationadipocyte hypertrophyWBCs
spellingShingle Federica Zatterale
Gregory Alexander Raciti
Immacolata Prevenzano
Alessia Leone
Michele Campitelli
Veronica De Rosa
Francesco Beguinot
Luca Parrillo
Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes
Biomolecules
epigenetics
immune system
obesity and type 2 diabetes
inflammation
adipocyte hypertrophy
WBCs
title Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes
title_full Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes
title_fullStr Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes
title_full_unstemmed Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes
title_short Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes
title_sort epigenetic reprogramming of the inflammatory response in obesity and type 2 diabetes
topic epigenetics
immune system
obesity and type 2 diabetes
inflammation
adipocyte hypertrophy
WBCs
url https://www.mdpi.com/2218-273X/12/7/982
work_keys_str_mv AT federicazatterale epigeneticreprogrammingoftheinflammatoryresponseinobesityandtype2diabetes
AT gregoryalexanderraciti epigeneticreprogrammingoftheinflammatoryresponseinobesityandtype2diabetes
AT immacolataprevenzano epigeneticreprogrammingoftheinflammatoryresponseinobesityandtype2diabetes
AT alessialeone epigeneticreprogrammingoftheinflammatoryresponseinobesityandtype2diabetes
AT michelecampitelli epigeneticreprogrammingoftheinflammatoryresponseinobesityandtype2diabetes
AT veronicaderosa epigeneticreprogrammingoftheinflammatoryresponseinobesityandtype2diabetes
AT francescobeguinot epigeneticreprogrammingoftheinflammatoryresponseinobesityandtype2diabetes
AT lucaparrillo epigeneticreprogrammingoftheinflammatoryresponseinobesityandtype2diabetes